Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Chan AT et al. - The greater efficacy of high-dose celecoxib, compared with the low-dose, in preventing colorectal adenoma appears confined to individuals with slow metabolizer genotypes. Genetic variability influences susceptibility to the potential benefits and hazards of celecoxib.

Related Articles

Visceral Fat Volume and the Prevalence of Colorectal Adenoma
American Journal of Epidemiology, 11/19/09    Relevance Score: 70%

A randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma
American Journal of Clinical Nutrition, 10/29/09    Relevance Score: 69%

The effect of aspirin in the recurrence of colorectal adenomas: a meta-analysis of randomized controlled trials
Colorectal Disease, 10/15/09    Relevance Score: 69%

Analysis of Candidate Genes in Occurrence and Growth of Colorectal Adenomas
Journal of Oncology, 11/02/09    Relevance Score: 68%

A Prospective Randomized Study on Computed Virtual Chromoendoscopy Versus Conventional Colonoscopy for the Detection of Small Colorectal Adenomas
Digestive Diseases and Sciences, 10/21/09    Relevance Score: 68%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address